Redefining medical device coatings through nature-inspired innovation

LipoCoat is a medical device coating company. Our  coating platforms are designed to improve comfort, safety, and performance - providing advantages such as better wetting, lubricity, infection control, and ultrasound visibility, while also contributing to sustainability by minimizing environmental impact.

The LipoCoat office in Enschede

Born from nature, built for better healthcare

We founded "The Lipocoat Group" with a clear mission: to solve complex medical challenges without using harmful substances. In less than ten years, The Lipocoat Group has grown to develop, manufacture, and sell multiple medical coating solutions worldwide.

Our coating platforms transform surfaces to be hydrophilic, lubricious, and naturally anti-fouling, reducing bacterial and protein buildup without antibiotics or leachable agents. Additionally, we offer best-in-class, angle-independent ultrasound visibility for metallic, polymeric, and ceramic medical devices. This provides clinicians with real-time positional confidence during placement and supports advanced automated placement procedures.

We support partners from early feasibility through application development, testing, tech transfer, regulatory approval, and scale-up. Our solutions are future-proof and free of APIs, silicone, PFAS, and other harmful chemicals.

Laboratory work at LipoCoat
Milestones

The path from a university lab to the clinic

What began as an in-depth study into the functioning of human cell membranes evolved into an innovative coating technology. Our ambition is to become the leading partner for surface innovation in medical devices. We help manufacturers deliver safer, more comfortable, and easier-to-use products to clinicians and patients worldwide.

2015

Academic research begins at the University of Twente, exploring nature's own lipid bilayers for medical surfaces.

2017

First seed funding is secured and the management team expands to drive the technology forward.

2019

The company grows to 17 employees, builds its own lab, achieves ISO 13485 certification, and is named European Biotech Startup of the Year.

2020

A series A investment round closes, fueling expansion into catheter applications and new device frontiers.

2024

SonoCoat ultrasound visibility technology launches, adding a new dimension to interventional device performance.

2026

Facilities expand to meet global demand, scaling production capacity for the next generation of medical devices.

Team

Management team

The bright minds behind the membrane. Our management team includes scientists, entrepreneurs, and engineers.

Jasper van Weerd
CEO / Founder

Jasper van Weerd is CEO of Lipocoat and founder of the LipoCoat coating technology, translating lipid-based science into products that improve the safety, comfort and performance of medical devices.

Alain le Loux
CFO / Angel Investor, Lipocoat

Alain le Loux is CFO and angel investor at Lipocoat, bringing deep tech venture capital experience from his role as General Partner at Cottonwood Technology Fund.

Emma Luong-Van
Chief Technology Officer

Emma Luong-Van is Chief Technology Officer at Lipocoat, leading the technology and R&D behind Lipocoat's coating platforms.

Bram Pape
Chief Operation Officer

Bram is Chief Operating Officer at Lipocoat, overseeing the operational side of the LipoCoat and SonoCoat coating platforms.

Fabian Stein
Chief Business Development Officer (CBDO)

Fabian Stein leads Business Development and Global Sales for the Lipocoat Company, connecting the coating platforms to medical device manufacturers.

Join our mission

Build the future

We are looking for sharp minds who want to humanize medical technology. The work is hard and good.

FAQ

Common questions from medical device manufacturers about our facility, certifications and services.

How long has LipoCoat been developing medical coatings?

LipoCoat was founded in 2016 as a spin-off from the University of Twente. In under ten years we have grown into a company that develops, manufactures and sells multiple coating platforms, LipoCoat® and Sono-Coat®, to medical device manufacturers worldwide.

Does LipoCoat have its own lab and production facility?

Yes. In 2026 we expanded our facility in Enschede, the Netherlands, to 1,000 m², combining an internal R&D center, a cleanroom, a laboratory and production under one roof. This gives us full control over formulation, testing and manufacturing, and shorter lead times for our partners.

Is LipoCoat ISO 13485 certified?

Yes, LipoCoat is ISO 13485:2016 certified. Our coatings are tested according to ISO 10993-1 and meet EU MDR requirements, so the regulatory approval process for your device is simpler and the documentation you need is already in place.

Does LipoCoat offer services beyond applying a coating?

Yes. Alongside our coating platforms, we offer analytical R&D services to quantify biomaterials, medical devices and coatings using ASTM- and ISO-aligned standards. This includes surface measurements, biocompatibility testing, microbial evaluation and friction testing, giving you precise, traceable data for regulatory submissions and quality assurance.

Can the coating be tailored to our specific device?

Yes. Every application has different requirements for thickness, wettability or lubricity. Thanks to our platform technology, we can tailor the formulation to your exact specifications without changing the device's underlying mechanical properties or dimensions.

Where is LipoCoat based, and who do you work with?

LipoCoat is based in Enschede, the Netherlands, and works with medical device manufacturers worldwide, supporting applications such as catheters, needles and contact lenses.

Still have questions?

Please contact us to discuss your project.